Review: Approving, Using JAK Inhibitors for Better Alopecia Areata Outcomes

Retrieved on: 2024-11-14 15:09:01

Tags for this article:

Click the tags to see associated articles and topics

Review: Approving, Using JAK Inhibitors for Better Alopecia Areata Outcomes. View article details on hiswai:

Excerpt

JAK inhibitors like baricitinib, ritlecitinib, and brepocitinib show promise in treating alopecia areata, with baricitinib approved by FDA and EMA.

Article found on: www.ajmc.com